HR 1076 · 118th Congress 2023–2025, ended

Preventing the Financing of Illegal Synthetic Drugs Act

Latest action · Sep 13, 2024 Became Public Law No: 118-79.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 17, 2023
  2. Passed HouseMay 22, 2023
  3. Passed SenateJul 23, 2024
  4. To the PresidentSep 11, 2024
  5. Became lawSep 13, 2024Public Law 118-79

Summary

Preventing the Financing of Illegal Synthetic Drugs Act

This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.

Recorded votes 1

Newest first. Open one to see how every member voted.

Roll callQuestionResultDate
House 228Passed402–2May 22, 2023

Cosponsors 8

Members who signed on, in the order they did. Signatures ran from Feb 17, 2023 to May 22, 2023; 2 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-TNAndrew OglesOriginalFeb 17, 2023
D-COBrittany PettersenOriginalFeb 17, 2023
R-ORLori Chavez-DeRemerFeb 28, 2023
R-NYMichael LawlerFeb 28, 2023
R-WIBryan SteilMay 22, 2023
R-FLByron DonaldsMay 22, 2023
D-NHChris PappasMay 22, 2023
D-WAMarie Gluesenkamp PerezMay 22, 2023

Committees 4

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseFinancial Services Committee
Referred Feb 17, 2023Markup Feb 28, 2023Reported May 22, 2023
HouseJudiciary Committee
Referred Feb 17, 2023Discharged May 22, 2023
HouseEnergy and Commerce Committee
Referred Feb 17, 2023Discharged May 22, 2023
Health Subcommittee
Referred Feb 24, 2023
SenateBanking, Housing, and Urban Affairs Committee
Referred May 30, 2023Discharged Jul 23, 2024

Actions 23

Everything that happened, newest first.

  1. Sep 13, 2024Signed by President.
  2. Sep 13, 2024Became Public Law No: 118-79.
  3. Sep 11, 2024Presented to President.
  4. Jul 24, 2024Message on Senate action sent to the House.
  5. Jul 23, 2024Senate Committee on Banking, Housing, and Urban Affairs discharged by Unanimous Consent.
  6. Jul 23, 2024Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent. (consideration: CR S5319; text: CR S5319)
  7. May 30, 2023Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  8. May 22, 2023Reported (Amended) by the Committee on Financial Services. H. Rept. 118-75, Part I.
  9. May 22, 2023Committee on the Judiciary discharged.
  10. May 22, 2023Committee on Energy and Commerce discharged.
  11. May 22, 2023Placed on the Union Calendar, Calendar No. 55.
  12. May 22, 2023Mr. Luetkemeyer moved to suspend the rules and pass the bill, as amended.
  13. May 22, 2023Considered under suspension of the rules. (consideration: CR H2469-2471)
  14. May 22, 2023DEBATE - The House proceeded with forty minutes of debate on H.R. 1076.
  15. May 22, 2023At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  16. May 22, 2023Considered as unfinished business. (consideration: CR H2483)
  17. May 22, 2023Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
  18. May 22, 2023Motion to reconsider laid on the table Agreed to without objection.
  19. Feb 28, 2023Committee Consideration and Mark-up Session Held.
  20. Feb 28, 2023Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
  21. Feb 24, 2023Referred to the Subcommittee on Health.
  22. Feb 17, 2023Introduced in House
  23. Feb 17, 2023Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 3

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S5490Charles E. Schumer D-NYJul 25, 2024
SenateDebate and remarks S5175, S5319Charles E. Schumer D-NYJul 23, 2024
HouseDebate and remarks H2469–H2471Text printed H2469Recorded votes H2483enactBlaine Luetkemeyer R-MO, Brittany Pettersen D-CO, Joyce Beatty D-OH, Monica De La Cruz R-TXMay 22, 2023

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimate

  1. Mar 6, 2023H.R. 1076, Preventing the Financing of Illegal Synthetic Drugs ActAs ordered reported by the House Committee on Financial Services on February 28, 2023

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Regulations with an Effect on Interstate Commerce Article I, Section 8, clause 3 (Commerce Clause) The single subject of this legislation is: Drug Trafficking Funding

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 33, February 17, 2023, page H855.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 118-16OVERSIGHT OF THE FINANCIAL CRIMES ENFORCEMENT NETWORK (FinCEN) AND THE OFFICE OF TERRORISM AND FINANCIAL INTELLIGENCE (TFI)294 pagesFinancial Services CommitteeApr 27, 2023

CRS reports 6

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 6

Products on other subjects that cite it, usually among other measures.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2227Preventing the Financing of Illegal Synthetic Drugs ActRelated billJul 11, 2023

Titles 6

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require the Comptroller General of the United States to carry out a study on the trafficking into the United States of synthetic drugs, and related illicit finance, and for other purposes.
Short Title(s) as Introduced
Preventing the Financing of Illegal Synthetic Drugs Act
Short Title(s) as Reported to House
Preventing the Financing of Illegal Synthetic Drugs Act
Short Title(s) as Passed House
Preventing the Financing of Illegal Synthetic Drugs Act
Short Titles from ENR (Enrolled) bill text
Preventing the Financing of Illegal Synthetic Drugs Act
Short Titles from RFS (Referred to Senate) bill text
Preventing the Financing of Illegal Synthetic Drugs Act

Subjects

Assigned by the Library of Congress. Policy area: Government Operations and Politics.

Text 5

Each version as it was printed, newest first.

  1. —Enrolled Bill
  2. May 30, 2023Referred in Senate
  3. May 22, 2023Reported in House
  4. May 22, 2023Engrossed in House
  5. Feb 17, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.